United States · Health Care · USD · Annual
Reported figures and Equlion model projections for the next 5 years.
Sector average (own scale)
| Key metrics | Actual |
|---|
Amounts in USD; stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for Hepion Pharmaceuticals, Inc.? It covers the balance sheet, income statement, cash flow and Equlion model projections.
| Forecast |
|---|
| Metric | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|
| Total Assets | $18,094,397.00 | $3,308,517.00 | $3,308,517.00 | $3,308,517.00 | $3,308,517.00 | $3,308,517.00 |
|---|---|---|---|---|---|---|
| Sector average | $3,469,120,327.60 | $3,402,844,699.02 | $3,516,665,422.28 | $3,537,396,325.28 | $3,954,880,656.28 | $4,602,556,361.88 |
| Net Income | -$48,926,042.00 | -$48,825,642.65 | -$48,745,871.16 | -$49,410,158.66 | -$47,820,419.51 | -$47,697,301.28 |